Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (263)
Cancellation by sponsor (201)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (16)
2023 (30)
2022 (102)
2021 (32)
2020 (52)
2019 (59)
2018 (35)
2017 (51)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (10)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Results for "[search-keyword]"

Search

Sponsor content

492 result(s) found, displaying 381 to 390

TEMOZOLOMIDE AN temozolomide 100 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
TEMOZOLOMIDE AN temozolomide 140 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
TEMOZOLOMIDE AN temozolomide 20mg capsule bottle Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
CARVEDILOL CH carvedilol 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
CARVEDILOL CH carvedilol 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
LERCANIDIPINE GH lercanidipine hydrochloride 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
LERCANIDIPINE GH lercanidipine hydrochloride 20 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
MODAFINIL AN modafinil 100 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
PHARMACY CHOICE COLD SORE ONE DOSE TREATMENT famciclovir 500mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

14 May 2018

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
GALANTAMINE SR CH galantamine (as hydrobromide) 8mg modified release capsules blister pack (225191)

3 July 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for GALANTAMINE SR CH galantamine (as hydrobromide) 8mg modified release capsules blister pack.

Pages

First page
Previous page
…
Page 35
Page 36
Page 37
Page 38
Current page 39
Page 40
Page 41
Page 42
Page 43
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.